FACULTAD DE CIENCIAS BIOMÉDICAS Y DE LA SALUD
Facultad
University of Amsterdam
Ámsterdam, HolandaPublicaciones en colaboración con investigadores/as de University of Amsterdam (25)
2023
-
Antithrombotic Strategy in Secondary Prevention for High-Risk Patients with Previous Acute Coronary Syndrome: Overlap between the PEGASUS Eligibility and the COMPASS Eligibility in a Large Multicenter Registry
American Journal of Cardiovascular Drugs, Vol. 23, Núm. 1, pp. 77-87
-
Drug reactions with eosinophilia and systemic symptoms induced by immune checkpoint inhibitors: an international cohort of 13 cases
Melanoma research, Vol. 33, Núm. 2, pp. 155-158
-
Optimal medical therapy improves outcomes in patients with diabetes mellitus and acute myocardial infarction
Diabetes Research and Clinical Practice, Vol. 203
2021
-
Case Studies in Physiology: Physiological and clinical effects of temporary diaphragm pacing in two patients with ventilator-induced diaphragm dysfunction
Journal of Applied Physiology, Vol. 130, Núm. 6, pp. 1736-1742
-
Evaluation of optimal medical therapy in acute myocardial infarction patients with prior stroke
Therapeutic Advances in Chronic Disease, Vol. 12
-
Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets
The Lancet, Vol. 397, Núm. 10270, pp. 199-207
-
Ticagrelor or Clopidogrel After an Acute Coronary Syndrome in the Elderly: A Propensity Score Matching Analysis from 16,653 Patients Treated with PCI Included in Two Large Multinational Registries
Cardiovascular Drugs and Therapy, Vol. 35, Núm. 6, pp. 1171-1182
2020
-
Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: Insights from the BleeMACS and RENAMI registries
American Heart Journal, Vol. 220, pp. 108-115
-
Beta-blocker effect on ST-segment: A prespecified analysis of the EARLY-BAMI randomised trial
Open Heart, Vol. 7, Núm. 2
-
Efficacy and Safety of Clopidogrel, Prasugrel and Ticagrelor in ACS Patients Treated with PCI: A Propensity Score Analysis of the RENAMI and BleeMACS Registries
American Journal of Cardiovascular Drugs, Vol. 20, Núm. 3, pp. 259-269
-
Impact of renin-angiotensin system blockade on the prognosis of acute coronary syndrome based on left ventricular ejection fraction
Revista espanola de cardiologia (English ed.), Vol. 73, Núm. 2, pp. 114-122
-
Incidence, predictors and prognostic impact of intracranial bleeding within the first year after an acute coronary syndrome in patients treated with percutaneous coronary intervention
European Heart Journal: Acute Cardiovascular Care, Vol. 9, Núm. 7, pp. 764-770
-
P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects
European heart journal. Cardiovascular pharmacotherapy, Vol. 6, Núm. 1, pp. 31-42
-
The impact of optimal medical therapy on patients with recurrent acute myocardial infarction: Subanalysis from the BleeMACS study
International Journal of Cardiology, Vol. 318, pp. 1-6
2019
-
Contribution of altered endocannabinoid system to overactive mTORC1 signaling in focal cortical dysplasia
Frontiers in Pharmacology, Vol. 9, Núm. JAN
-
Monitoring the health of transitioning professional footballers: Protocol of an observational prospective cohort study
BMJ Open Sport and Exercise Medicine, Vol. 5, Núm. 1
-
Reduced Time to Suppression among Neonates with HIV Initiating Antiretroviral Therapy Within 7 Days after Birth
Journal of Acquired Immune Deficiency Syndromes, Vol. 82, Núm. 5, pp. 483-490
2018
-
Development and external validation of a post-discharge bleeding risk score in patients with acute coronary syndrome: The BleeMACS score
International Journal of Cardiology, Vol. 254, pp. 10-15
-
Prediction of Post-Discharge Bleeding in Elderly Patients with Acute Coronary Syndromes: Insights from the BleeMACS Registry
Thrombosis and Haemostasis, Vol. 118, Núm. 5, pp. 929-938
2017
-
Cardiovascular efficacy and safety of bococizumab in high-risk patients
New England Journal of Medicine, Vol. 376, Núm. 16, pp. 1527-1539